Krónikus limfoid leukémia (CLL): vizsgálatok itt: Egyesült Államok
184 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
- Where
- Boston, Fort Wayne, Seattle, St Louis, Tampa, Westwood
- Életkor
- 18 év and over
- People
- 258 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06697184 · EU 2024-518829-15-00 - 2. fázisTaking peopleAcalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 20
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT04941716 - 2. fázisTaking peopleCMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Életkor
- 18 év to 75 év
- People
- 216
- Run by
- City of Hope Medical Center
See details and how to joinNCT06059391 - 3. fázisTaking peopleA Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
- Where
- Aurora, Baltimore, Baton Rouge, Boston, Chapel Hill, Charlotte, Chattanooga, Chicago, Cincinnati, Dallas, Eugene, Grand Rapids, Hershey, Iowa City, Laguna Hills, Louisville, Nashville, New Haven, New York, Niles, Norwich, Omaha, Orange, Palo Alto, Philadelphia, Pittsburgh, Rochester, San Antonio, San Diego, Santa Fe, Seattle, Sewell, Tyler, Vancouver, Waukee, Westbury, Weston, Winston-Salem
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06943872 · EU 2024-517131-52-00 - 1. fázisTaking peopleA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- City of Hope Medical Center
See details and how to joinNCT07020533 - 2. fázisTaking peopleMAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without Obinutuzumab
- Where
- Boston, Charlotte, Durham, Winston-Salem
- Életkor
- 18 év to 130 év
- People
- 80 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07024706 · EU 2024-518858-17-00 - 2. fázisTaking peoplePhase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
- Where
- Atlanta, Boston, Chapel Hill, Columbus
- Életkor
- 18 év and over
- People
- 70
- Run by
- Christine Ryan
See details and how to joinNCT06043674 - 2. fázisNot yet taking people in Egyesült ÁllamokTacabrutideg and Sonrotoclax, With Response-Guided Obinutuzumab, for the Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 30
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07887061 - 3. fázisTaking peopleWisconsin Ginseng for Decreasing Cancer Related Fatigue
- Where
- Albert Lea, Bemidji, Brainerd, Deer River, Detroit Lakes, Duluth, Fosston, Hibbing, Mankato, Monticello, Rochester, Sandstone, Thief River Falls, Virginia, Worthington
- Életkor
- 18 év and over
- People
- 222
- Run by
- Mayo Clinic
See details and how to joinNCT06395441 - 1/2. fázisTaking peopleAnti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 132
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06364423 - 1. fázisTaking peopleA Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- Where
- Chicago, Cincinnati, Duarte, Grand Rapids, Omaha, Seattle, St Louis
- Életkor
- 18 év and over
- People
- 106 worldwide
- Run by
- Umoja Biopharma
See details and how to joinNCT06528301 - 1. fázisTaking peopleA Study of APG-3288 in Relapsed/Refractory Blood Cancers
- Where
- East Brunswick, Grand Rapids, Houston, Jacksonville, Los Angeles
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT07424833 - 1. fázisTaking peoplePomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
- Where
- Ann Arbor
- Életkor
- 18 év and over
- People
- 12
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07532525 - 2. fázisTaking peopleNemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 25
- Run by
- Jennifer Woyach
See details and how to joinNCT07557056 - 3. fázisTaking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Baltimore, Bethesda, Cincinnati, Coral Springs, Denver, Durham, Hackensack, Hershey, Houston, Jacksonville, Lafayette, Milwaukee, Morristown, New York, Orange, Seattle, The Bronx
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - No phaseTaking peopleEstablishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
- Where
- Boston
- Életkor
- 18 év and over
- People
- 1500
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT00131014 - No phaseTaking peopleUnderstanding Chronic Lymphocytic Leukemia
- Where
- Boston
- Életkor
- 18 év and over
- People
- 2750
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04028531 - 3. fázisTaking peopleAdding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
- Where
- Baton Rouge, Bellevue, Bloomington, Brighton, Canton, Carthage, Chapel Hill, Chelsea, City of Saint Peters, Creve Coeur, Danville, Decatur, Durham, Effingham, Eureka, Galesburg, Irvine, Kewanee, Kirkland, Laguna Hills, Livonia, Macomb, Mattoon, Menomonee Falls, Milwaukee, Mukwonago, New Berlin, Normal, Oak Creek, Oconomowoc, O'Fallon, Orange, Ottawa, Pekin, Peoria, Peru, Philadelphia, Pontiac, Princeton, Richmond, Salt Lake City, Seattle, Shiloh, Springfield, St Louis, Urbana, Washington, Waukesha, West Bend, Ypsilanti
- Életkor
- 18 év and over
- People
- 102
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT07220187 - 2. fázisTaking peopleLoncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 36
- Run by
- City of Hope Medical Center
See details and how to joinNCT05672251 - 2. fázisTaking peopleTesting the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
- Where
- Boston, Chapel Hill, Columbus, Duarte, Irvine, New York, Pittsburgh, Sacramento, Salt Lake City
- Életkor
- 18 év and over
- People
- 20
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07061951 - 3. fázisNot yet taking people in Egyesült ÁllamokSurovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Where
- Basking Ridge, Bethesda, Boston, Chicago, Cleveland, Denver, Houston, Kansas City, La Jolla, Louisville, New Haven, Pittsburgh, Rochester
- Életkor
- 18 év to 18 év
- People
- 420 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07509151 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Augusta, Baton Rouge, Bethesda, Birmingham, Boston, Buffalo, Chattanooga, Detroit, Fort Collins, Houston, Iowa City, Jacksonville, La Jolla, Las Vegas, Louisville, Miami, Nashville, Newnan, New York, Palo Alto, Phoenix, Richmond, Rochester, Santa Monica, Scottsdale, Seattle, Tampa, Tucson, Zion
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - No phaseCsak meghívásosHypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors
- Where
- Philadelphia
- Életkor
- 22 év and over
- People
- 50
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT06211413 - Korai 1. fázisTaking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - 1. fázisTaking peopleActivated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Where
- Houston
- Életkor
- Up to 75 év
- People
- 64
- Run by
- Baylor College of Medicine
See details and how to joinNCT01853631